In Brief: Ohmeda's Harvard 2
This article was originally published in The Gray Sheet
Ohmeda's Harvard 2: Dual syringe pump U.S. shipments to commence in "mid-November," making it "the only multiple syringe pump available in the U.S.," Ohmeda claims. Liberty Corner, New Jersey-based Ohmeda has worldwide distribution rights to the pump under a spring 1997 agreement with developer and manufacturer Harvard Clinical Technology. The device received 510(k) clearance in September 1995. International distribution in slated for 1998...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.